| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,472 |
4,008 |
$1.20M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,621 |
15,152 |
$1.08M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,276 |
8,543 |
$362K |
| 80053 |
Comprehensive metabolic panel |
11,324 |
10,288 |
$109K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,376 |
12,119 |
$105K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
951 |
909 |
$93K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
894 |
832 |
$38K |
| 81001 |
|
2,736 |
2,531 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
1,082 |
1,014 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
516 |
479 |
$6K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
427 |
411 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,991 |
2,696 |
$4K |
| 83690 |
|
646 |
606 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
128 |
126 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
286 |
267 |
$3K |
| 81025 |
|
704 |
664 |
$2K |
| 80061 |
Lipid panel |
126 |
125 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
945 |
855 |
$2K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
29 |
27 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,150 |
1,018 |
$1K |
| 87070 |
|
92 |
86 |
$956.69 |
| 84484 |
|
113 |
104 |
$924.73 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
130 |
70 |
$863.10 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
70 |
65 |
$790.85 |
| 85610 |
|
196 |
177 |
$686.30 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
35 |
28 |
$353.50 |
| 85730 |
|
181 |
163 |
$346.91 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
568 |
524 |
$144.78 |
| 84443 |
Thyroid stimulating hormone (TSH) |
15 |
13 |
$130.13 |
| 84134 |
|
19 |
17 |
$123.50 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
36 |
24 |
$72.12 |
| 82947 |
|
12 |
12 |
$46.50 |
| 81003 |
|
13 |
13 |
$29.61 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
639 |
593 |
$2.69 |
| A9270 |
Non-covered item or service |
236 |
213 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
464 |
352 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
104 |
88 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
113 |
92 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13 |
12 |
$0.00 |